Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 04, 2023 Filed Oct 6, 2023 20:47 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 70.0883 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052330 · doc4.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,183.7631 Underlying: Common Shares · 70.0883 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F3 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:47 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 6,634.2812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052334 · doc4.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774,642.803 Underlying: Common Shares · 6,634.2812 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:47 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 4,422.8542 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052334 · doc4.xml · derivative · entry 3 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,428.5353 Underlying: Common Shares · 4,422.8542 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 291.327 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,016.3949 Underlying: Common Shares · 291.327 shares Expires 2026-02-22 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 125.882 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 17 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,698.4422 Underlying: Common Shares · 125.882 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: The restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F15 · derivative.expiration_date: The restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 314.7226 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,748.151 Underlying: Common Shares · 314.7226 shares Expires 2025-02-25 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 116.7468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 15 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,631.7773 Underlying: Common Shares · 116.7468 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F13 · derivative.expiration_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 189.357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 14 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,110.0082 Underlying: Common Shares · 189.357 shares Expires 2024-02-19 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 49.4118 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 13 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,769.5022 Underlying: Common Shares · 49.4118 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 31.0885 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 12 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,630.0014 Underlying: Common Shares · 31.0885 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 245.5909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,676.0848 Underlying: Common Shares · 245.5909 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 73.3924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,569.5612 Underlying: Common Shares · 73.3924 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 505.8998 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,070.7037 Underlying: Common Shares · 505.8998 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 22, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:49 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 86.5291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052337 · doc4.xml · derivative · entry 7 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,103.4532 Underlying: Common Shares · 86.5291 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 116.5308 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 14 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,606.558 Underlying: Common Shares · 116.5308 shares Expires 2026-02-22 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest 100% on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 61.2041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,146.4133 Underlying: Common Shares · 61.2041 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 134.8798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 12 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,749.057 Underlying: Common Shares · 134.8798 shares Expires 2025-02-25 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2022 and to the extent earned will vest 100% on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 49.4202 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 11 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,770.4809 Underlying: Common Shares · 49.4202 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 21.9032 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 10 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,557.501 Underlying: Common Shares · 21.9032 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 70.6556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,250.0031 Underlying: Common Shares · 70.6556 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 98.2364 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,470.4339 Underlying: Common Shares · 98.2364 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 35.8956 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 7 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,191.2966 Underlying: Common Shares · 35.8956 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 202.3599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,628.2815 Underlying: Common Shares · 202.3599 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:53 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 44.6608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052345 · doc4.xml · derivative · entry 5 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,214.7617 Underlying: Common Shares · 44.6608 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,631.6798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 16 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,284.5067 Underlying: Common Shares · 2,631.6798 shares Expires 2026-02-22 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending May 21, 2028 and to the extent earned will vest on May 28, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 227.342 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 15 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,545.2843 Underlying: Common Shares · 227.342 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F15 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,124.0104 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 14 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,243.5469 Underlying: Common Shares · 1,124.0104 shares Expires 2022-02-25 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 209.0658 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 13 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,411.2823 Underlying: Common Shares · 209.0658 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 788.9874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 12 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,125.0344 Underlying: Common Shares · 788.9874 shares Expires 2024-02-19 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 92.2762 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 11 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,774.504 Underlying: Common Shares · 92.2762 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 129.5352 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125.0056 Underlying: Common Shares · 129.5352 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,964.7271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,408.6784 Underlying: Common Shares · 1,964.7271 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 142.0007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,580.5122 Underlying: Common Shares · 142.0007 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,276.5492 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,818.1665 Underlying: Common Shares · 2,276.5492 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:50 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 134.7009 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052341 · doc4.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,728.1656 Underlying: Common Shares · 134.7009 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 647.3932 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 14 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,591.9887 Underlying: Common Shares · 647.3932 shares Expires 2026-02-22 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 137.6018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 13 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,066.8826 Underlying: Common Shares · 137.6018 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 359.6765 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 12 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,997.1341 Underlying: Common Shares · 359.6765 shares Expires 2025-02-25 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 95.0332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 11 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,096.4241 Underlying: Common Shares · 95.0332 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 252.476 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 10 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,480.011 Underlying: Common Shares · 252.476 shares Expires 2024-02-19 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 36.967 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 9 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,316.4016 Underlying: Common Shares · 36.967 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 41.4513 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 8 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,840.0018 Underlying: Common Shares · 41.4513 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 392.9454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 7 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,881.7357 Underlying: Common Shares · 392.9454 shares Expires 2025-02-21 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 26.6712 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 6 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,114.2228 Underlying: Common Shares · 26.6712 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:51 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 54.3539 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052343 · doc4.xml · derivative · entry 4 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,346.5564 Underlying: Common Shares · 54.3539 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F3 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:55 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 190.9353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052347 · doc4.xml · derivative · entry 14 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,297.1239 Underlying: Common Shares · 190.9353 shares Expires 2026-02-22 F15 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning on January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:55 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 77.9652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052347 · doc4.xml · derivative · entry 13 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,104.6504 Underlying: Common Shares · 77.9652 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:55 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 222.6774 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052347 · doc4.xml · derivative · entry 12 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,003.921 Underlying: Common Shares · 222.6774 shares Expires 2022-02-25 F13 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning on January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:55 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 76.723 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052347 · doc4.xml · derivative · entry 11 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,959.5956 Underlying: Common Shares · 76.723 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:55 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 157.7722 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052347 · doc4.xml · derivative · entry 10 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,424.3928 Underlying: Common Shares · 157.7722 shares Expires 2024-02-19 F11 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning on January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.